Nicholas A. Smith

Array ( [id] => 9983799 [patent_doc_number] => 09029508 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-12 [patent_title] => 'Dual variable domain immunoglobulins and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/431460 [patent_app_country] => US [patent_app_date] => 2009-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 141606 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12431460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480095 [patent_doc_number] => 20090203052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'NOVEL SOLUBLE CD14 ANTIGEN' [patent_app_type] => utility [patent_app_number] => 12/395298 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 58217 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203052.pdf [firstpage_image] =>[orig_patent_app_number] => 12395298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070688 [patent_doc_number] => 20110045538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'Peptide, Use Of The Peptide, Method For The Production Of The Peptide, Solid Support Having The Peptide Immobilized Thereon, And Method For Production Of The Solid Support' [patent_app_type] => utility [patent_app_number] => 12/864368 [patent_app_country] => US [patent_app_date] => 2009-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 22470 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20110045538.pdf [firstpage_image] =>[orig_patent_app_number] => 12864368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6351096 [patent_doc_number] => 20100331239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'CD14 AND PEPTIDES THEREOF FOR PROTECTION OF CELLS AGAINST CELL DEATH' [patent_app_type] => utility [patent_app_number] => 12/864940 [patent_app_country] => US [patent_app_date] => 2009-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 7346 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331239.pdf [firstpage_image] =>[orig_patent_app_number] => 12864940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490016 [patent_doc_number] => 20090291087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'MODULATING ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 12/358891 [patent_app_country] => US [patent_app_date] => 2009-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 34845 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291087.pdf [firstpage_image] =>[orig_patent_app_number] => 12358891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9588801 [patent_doc_number] => 08778339 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-15 [patent_title] => 'Combination of FcγRIIB-specific antibodies and CD20-specific antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/342305 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 62386 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 292 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12342305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5503011 [patent_doc_number] => 20090163699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Fc VARIANTS WITH ALTERED BINDING TO FcRn' [patent_app_type] => utility [patent_app_number] => 12/341769 [patent_app_country] => US [patent_app_date] => 2008-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 26376 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20090163699.pdf [firstpage_image] =>[orig_patent_app_number] => 12341769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289859 [patent_doc_number] => 20100158901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'ANTI-CD19 ANTIBODY THERAPY FOR AUTOIMMUNE DISEASE' [patent_app_type] => utility [patent_app_number] => 12/325426 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 61628 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158901.pdf [firstpage_image] =>[orig_patent_app_number] => 12325426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6301969 [patent_doc_number] => 20100068136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'Anti-CD19 Antibodies' [patent_app_type] => utility [patent_app_number] => 12/266999 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23901 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068136.pdf [firstpage_image] =>[orig_patent_app_number] => 12266999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7762752 [patent_doc_number] => 08114966 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-14 [patent_title] => 'Peptide-based passive immunization therapy for treatment of atherosclerosis' [patent_app_type] => utility [patent_app_number] => 12/258745 [patent_app_country] => US [patent_app_date] => 2008-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 17 [patent_no_of_words] => 9381 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/114/08114966.pdf [firstpage_image] =>[orig_patent_app_number] => 12258745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7786030 [patent_doc_number] => 20120047586 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-02-23 [patent_title] => 'POLYPEPTIDE HAVING ENHANCED EFFECTOR FUNCTION' [patent_app_type] => utility [patent_app_number] => 12/739480 [patent_app_country] => US [patent_app_date] => 2008-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 31213 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0047/20120047586.pdf [firstpage_image] =>[orig_patent_app_number] => 12739480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7786030 [patent_doc_number] => 20120047586 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-02-23 [patent_title] => 'POLYPEPTIDE HAVING ENHANCED EFFECTOR FUNCTION' [patent_app_type] => utility [patent_app_number] => 12/739480 [patent_app_country] => US [patent_app_date] => 2008-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 31213 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0047/20120047586.pdf [firstpage_image] =>[orig_patent_app_number] => 12739480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6230083 [patent_doc_number] => 20100184143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Immunoglobulins comprising predominantly a Man3GlcNAc2 glycoform' [patent_app_type] => utility [patent_app_number] => 12/287423 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20772 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184143.pdf [firstpage_image] =>[orig_patent_app_number] => 12287423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501689 [patent_doc_number] => 20090162377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Immunoglobulins comprising predominantly a Gal2GlcNAc2Man3GlcNAc2 glycoform' [patent_app_type] => utility [patent_app_number] => 12/284399 [patent_app_country] => US [patent_app_date] => 2008-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19822 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162377.pdf [firstpage_image] =>[orig_patent_app_number] => 12284399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5508009 [patent_doc_number] => 20090081216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'TREATMENT OF PATHOLOGIES WHICH ESCAPE THE IMMUNE RESPONSE, USING OPTIMIZED ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/234609 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4701 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081216.pdf [firstpage_image] =>[orig_patent_app_number] => 12234609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6635957 [patent_doc_number] => 20100226925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'Homogeneous Antibody Populations' [patent_app_type] => utility [patent_app_number] => 12/678130 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 30751 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20100226925.pdf [firstpage_image] =>[orig_patent_app_number] => 12678130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272475 [patent_doc_number] => 20090076251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'FcGammaRIIB Specific Antibodies and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/186058 [patent_app_country] => US [patent_app_date] => 2008-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 63 [patent_no_of_words] => 86748 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076251.pdf [firstpage_image] =>[orig_patent_app_number] => 12186058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9844472 [patent_doc_number] => 08946387 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'FcγRIIB specific antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/186065 [patent_app_country] => US [patent_app_date] => 2008-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 144 [patent_no_of_words] => 86790 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12186065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4959683 [patent_doc_number] => 20080274108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'POLYPEPTIDE VARIANTS WITH ALTERED EFFECTOR FUNCTION' [patent_app_type] => utility [patent_app_number] => 12/171888 [patent_app_country] => US [patent_app_date] => 2008-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 40269 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274108.pdf [firstpage_image] =>[orig_patent_app_number] => 12171888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6623160 [patent_doc_number] => 20100311119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Single-domain antigen-binding proteins that bind mammalian IgG' [patent_app_type] => utility [patent_app_number] => 12/669034 [patent_app_country] => US [patent_app_date] => 2008-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16052 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311119.pdf [firstpage_image] =>[orig_patent_app_number] => 12669034 [rel_patent_id] =>[rel_patent_doc_number] =>)